NIH-funded research Sbir 2 grant

A new coating for hemodialysis catheters to prevent infections and improve function

Official title: Slippery Omniphobic Coating for Hemodialysis Catheter to Resist Fibrin Sheathing and Infection and Improve Patient Outcomes

Funded at Cerulean Scientific INC. · NIH-10894142 · Data updated 2026-11-12

This study is testing a new coating for hemodialysis catheters that helps prevent infections and improve how well they work, and it's for patients who are undergoing hemodialysis.

More Hemodialysis research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCerulean Scientific INC.
NIH-funded
Lab location1 site (Lancaster, United States)
Project startAugust 1, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$751,776
NIH project number5R44DK135256-02
Project IDNIH-10894142 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who are starting hemodialysis and require catheter placement for their treatment.

Less likely to help

Patients who are not undergoing hemodialysis or those who use alternative methods for dialysis may not benefit from this research.

What this research studies

This research focuses on developing a special coating for hemodialysis catheters that aims to prevent infections and improve their functionality. The coating is designed to resist the adhesion of bacteria and blood components, which are common causes of complications in patients undergoing hemodialysis. By using a tethered liquid perfluorocarbon coating, the study seeks to reduce the rates of catheter-related bloodstream infections and thrombosis, ultimately enhancing patient outcomes. Patients participating in this research may help test the effectiveness of this innovative approach.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of infections and complications associated with hemodialysis catheters, leading to better health outcomes for patients.

How similar studies have gone: While there have been various approaches to improve catheter performance, this specific coating technology is novel and has not been extensively tested in clinical settings.

Where this research is happening

  • Cerulean Scientific INC.
    Lancaster, United States
    Active

Researchers

  • Principal investigator: Mcfarland, Todd — Cerulean Scientific INC.
  • Study coordinator: Mcfarland, Todd

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.